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Abstract 
 
 Salmonella are usually transmitted to human by the consumption of contaminated foods 
and water. The prevalence of Salmonella varies depending on the water supply, waste 
disposal, food preparation practices, and climate. The highest incidence rates occur in 
children younger than 5 years of age, particularly those younger than 1 year, and in 
individuals older than 70 years of age. 
 
Human Salmonellosis caused by non-typhoidal Salmonella species (NTS) occurs with 
increasing frequencies in developed countries. The emergence of fluroquinolone resistant 
Salmonella poses a serious problem. Fluroquinolones are considered the treatment of 
choice in cases of acute salmonellosis. The increase in antimicrobial resistance has lead 
many countries to initiate surveillance program to monitor dissemination and detect the 
evolution of bacterial resistance. 
 
In this study, we evaluated the antimicrobial susceptibility of (NTS)  following the 
Clinical Laboratory Standard Institute recommendations. In addition, we determined the 
molecular mutations on gyrA that caused resistance to quinolones by PCR. To confirm 
and specify the changes that occurred on gyrA, representative samples were sequenced. 
 
Our results revealed that Salmonella serogroups C and D were the most common among 
clinical isolates, while serogroups C and B were the most common among food isolates. 
Antimicrobial susceptibility testing revealed that all strains tested were susceptible to 
ceftriaxone, most of the strains were susceptible to chloramphenicol, gentamicin and 
trimethoprim sulfametaxazole. To evaluate resistance to quinolones, nalidixic acid and 
ciprofloxacin were used. NTS were divided into three main groups designated as: 
Susceptible to both quinolones (SS), resistant to nalidixic acid but susceptible to 

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ciprofloxacin (RS) and resistant to both (RR). Antimicrobial susceptibilities in the 3 
groups in clinical and food isolates were 38% and 51% (SS), 30% and 30% (RS) and 30% 
and 15% (RR) respectively. 
 
The gyrA gene was amplified and resolved by agarose gel electrophoresis. A sharp band 
of 630 bp was obtained and restricted by  Hinf I enzyme.  Subsequent agarose gel 
electrophoresis revealed various size bands depending on the pattern of susceptibility or 
resistance of Salmonella isolates to nalidixic acid and ciprofloxacin. The SS pattern 
revealed 3 major bands of 250 bp, 150 bp and 100 bp. A faintly appearing fourth band of 
about 130 bp was also seen. Identical results were obtained with the RS group, with the 
RR pattern; two major bands of 350 bp and 150 bp were evident. A faintly appearing 
third band of 130 bp was also seen. 
 
The sequence results obtained for the SS pattern was normal with no mutations. The 
sequence obtained with the RS pattern revealed a mutation at position 87. A substitution 
of G to A (GAC became TAC).  The sequence obtained with the RR pattern revealed two 
mutations at positions 83 and 87. At position 83, a substitution of C to T (TCC became 
TTC) was detected. At position 87, the same type of mutation occurred as in the RS 
pattern was detected, a substitution of G to A (GAC became TAC).   
 
 The level of resistance to quinolones in this study among NTS isolates is alarming. This 
warrants the prohibition of the use of quinolones in chicken feed and the restriction of 
administring of quinolones without a prescription. 
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Introduction and Review of the Literature 
 
 
1.1 General characteristics of Salmonellae spp.      
Salmonellae are gram-negative bacilli, motile, non-encapsulated, non-spore-forming 
facultative anaerobes. It is named after the American microbiologist, Daniel Elmer 
Salmon.   Most strains ferment glucose, maltose, and mannitol but do not utilize 
lactose or sucrose. All pathogenic Salmonella other than S. typhi produce gas.  A wide 
variety of selective differential agars have been developed for the isolation of 
Salmonella from clinical specimen. All these agar based media contain sugars, dyes 
and bile salts (Cassar, and Cuschieri, 2003). Differentiation of most salmonellae relies 
on the results of biochemical tests such as the production of hydrogen sulfide and the 
non-fermentation of lactose.  The most commonly used media include salmonella-
shigella agar, Hektoen enteric agar, brilliant green agar, and Xylose-lysine-dextrose 
agar (XLD). Enrichment in selenite broth usually results in the inhibition of normal 
fecal flora such as Coliforms and enhancing the growth of Salmonella.  
 
 Salmonellae live in the intestinal tracts of humans and animals. Salmonella typhi and 
paratyphi A are strictly human pathogens. The transmission of Salmonella occurs 
through fecal contamination of food and water. Although Salmonella doesn't multiply 
well in the natural environment, but under favorable conditions they can survive for 
weeks in water and several years in the soil. 
 
 
 

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1.2 Classification 
The genus Salmonella is a member of the family Enterobacteriaceae. The taxonomy 
of the salmonellae is the most complex of all Enterobacteriaceae.  Classification of 
Salmonella spp. into serovars was done in accordance with the Kauffmann–White 
scheme, which gives serovar status to each antigenic type on the basis of somatic (O), 
capsular (Vi) and the flagellar (H) antigens.  
 
 There are two species in the genus Salmonella, Salmonella enterica and Salmonella 
bongori, formerly known as subspecies V Salmonella enterica is composed of six 
subspecies: subspecies enterica I, subspecies salamae II, subspecies arizonae IIIa, 
subspecies diarizonae IIIb, subspecies houtenae IV, and subspecies indica VI, 
(Murray, and Baron 1999; Anderson and Ziprin, 2001). Salmonella enterica subsp. 
enterica, subspecies I strains are commonly recovered from humans and warm 
blooded animals. Subsp. II, IIIa, IIIb, IV, VI strains and S. bongori are commonly 
isolated from environmental sources and cold blooded animals ((Murray, and Baron 
1999). For the sake of simplicity, the CDC recommends that Salmonella species be 
referred to only by their genus and serovar such as Salmonella typhi instead of the 
Salmonella enterica subspecies enterica serovar typhi. 
  
 There are more than 2,435 serotype Salmonella, most of which including Salmonella 
typhi belong to subspecies I. Serotyping of Salmonella is useful for diagnostic 
purposes and an important epidemiologic tool for defining out-breaks. Salmonella 
spp. are serotyped according to the "O" heat-stable somatic or cell wall antigens, the 
"H" flagellar antigens and the "Vi" virulence or capsular antigens. The Vi antigens are 
heat labile-capsular antigens found only on S. typhi, S. paratyphi C and S. dublin. The 

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capsular antigens may interfere and mask the O antigen so the bacteria will not 
agglutinate with the O antibodies. 
 
 1.3 Salmonella Pathogenesis 
 The primary mode of transmission of Salmonella is the fecal-oral route; however, 
airborne transmission is also possible. Oliveira et al found that pigs could be 
experimentally infected by inhaling Salmonella over short distances (Oliveira, et al 
2006). 
 
 Both non-specific and specific host defenses attempt to suppress infection with 
pathogenic organisms. After ingestion, the organism must survive the acid mileau of 
the gastric fluid. The vast majority of the bacteria perish in the stomach, but with a 
large inoculum, enough bacteria survive to reach the distal small intestine and colon. 
A study in mice, suggests that gut luminal contents and composition may be critical 
for establishing infection in the intestinal epithelium (Clark, et al, 1998).  Salmonella 
typhimurium failed to infect mice intestinal cells in vitro when inoculated in 
phosphate buffered saline (PBS), but invasion was enhanced with Luria-Bertani (LB) 
broth. The authors speculate that amino acid supply may be an essential signal for 
cellular invasion, since addition of tryptone and yeast extract to PBS (two ingredients 
of LB broth), resulted in epithelial infection by Salmonella. This suggests that 
salmonellae receive environmental cues that change their extra cellular lifestyle and 
invade target intestinal epithelial cells (Meyerholz, 2002). 
 
Bacteria preferentially adhered to microfold (M) cells associated with the follicle-
associated epithelium (FAE) initially, but later were observed invading other cell 

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types as well (goblet cells and enterocytes). This study suggests that M cells are 
targeted early in disease since they lack surface barriers such as glycocalyx and 
mucus, which is present on absorptive enterocytes and goblet cells (Van Asten, et al 
2005) Bacteria were also observed migrating through crevices formed by extruded 
enterocytes (a process of normal cell turn over), suggesting that Salmonella takes 
advantage of these sites for invasion as well (Figure1). 
 
 
 
 
 
 
 
Figure1: Various mechanisms for Salmonella invasion. Early in cellular invasion, 
Salmonella adheres and preferentially targets epithelial M cells (A) which lack surface 
barrier of mucus and glycocalyx. In later stages of infection, Salmonella can be 
observed invading enterocytes and goblet cells (B) or migrating through crevices 
formed by extruded enterocytes (Van Asten, et al 2005) 
 
 
Bacteria have evolved unique mechanisms for invading non-phagocytic host cells. 
This “forced entry” into cells allows pathogens to evade host defenses and invade 
target tissues. There are a multitude of gene products that are required for full 
virulence and host interaction. In enteric bacteria, these genes are arranged into large 
clusters on the chromosome called pathogenicity islands (SPI) so the proteins they 
encode can be efficiently produced at the correct time and location. Salmonella spp. 
possesses five pathogenicity islands, each encoding different virulence factors that are 
needed for different phases of bacterial invasion.   

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Further plasma membrane manipulations create invaginations and eventually seal off 
around the invading microorganism. This is often termed as macropinocytosis since it 
resembles the normal cellular mechanism of pinocytosis, but on a much larger  
scale. Once internalized, Salmonella have evolved mechanisms for avoiding 
degradation by lysosomal vesicles. The Salmonella containing vesicle (SCV) 
continues to manipulate the host cell by recruiting actin molecules to the vacuole 
surface. This actin coat may act as a protective barrier preventing fusion with host 
oxidase-containing vacuoles. Secluded in the SCV, the pathogen can replicate by 
harnessing components of the host cell. Translocation of bacteria to adjacent cells can 
occur across the basolateral border trafficking them into deeper structures of the 
lamina propria. In this region, the bacteria gain access to phagocytic cells, especially 
tissue macrophages for invasion and eventual dissemination to other organs. 
  
One study demonstrated that the spread of Salmonella from the intestinal mucosa to 
the liver and spleen is dependent on CD18-expressing macrophages and possibly 
dendritic cells (Vasques-Torres, et al., 1999). Infected phagocytic cells may allow cell 
mediated immune mechanisms to contain the infection. In neonates or the 
immunocompromised host, extraintestinal infections can occur resulting in 
septicemia, pneumonia, septic arthritis or meningitis. Some speculate that infected 
phagocytes may play a permissive role in allowing state of latent persistent infection 
(McCain, et al 1990; Powell, 1994). Studies in mice have found Salmonella 
typhimurium bacteremia peaked 30 minutes after gastrointestinal inoculation 
(Vasques-Torres, et al., 1999), and Salmonella can be identified in the ileocecal 
lymph nodes in esophagotomized pigs within 6 hours of intranasal inoculation 
(Fedorka-Cray, 1995).  
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1.4 Mechanisms of Diarrhea 
The classic feature of clinical salmonellosis in most vertebrate species is profuse, 
voluminous diarrhea. This occurs as a result of intestinal fluid losses by two 
mechanisms: (1) active fluid loss through secretory hyperstimulation and (2) passive 
fluid loss by inflammation mediated malabsorption. Salmonella produces various 
virulence factors including exotoxin, cytotoxin, enterotoxin and endotoxin that 
mediate the development of diarrhea (Murray,1986). Cytotoxin, as the name implies, 
causes intestinal epithelial cell damage either directly through chelation of cations in 
the mucosal cell membrane or indirectly via stimulation of cytokines and 
inflammation. By inflicting direct damage of absorptive villous enterocytes, bacterial 
cytotoxins lead to reduced absorptive capacity and result in loss of electrolytes and 
water. Another mediator of inflammation is bacterial LPS or endotoxin, which 
through its interaction with local macrophages triggers a profound inflammatory 
effect resulting in the influx of neutrophils. 
 
 Inflammatory mediators released by infiltrating leukocytes, such as cytokines, 
enzymes and oxygen species, provoke local tissue damage and contribute to the 
breach in mucosal integrity and intestinal malabsorption. Bacterial enterotoxins 
initiate diarrhea by binding to receptors that stimulate the second messenger systems 
of cAMP and cGMP, which secondarily activate enterocyte fluid hypersecretion 
(Jones, and Blikslager, 2002).  
 
Clinical salmonellosis is characterized by explosive and voluminous diarrhea, 
abdominal discomfort and systemic signs of toxemia including fever, mucous 
membrane injection with prolonged capillary refill time (CRT), anorexia, and 

 
	
depression. Accompanying signs of circulatory shock may be present especially if 
infection has advanced to bacteremia, including tachycardia, cool extremities, poor 
pulse quality and weakness. Milder infections are usually self-limiting, and patients 
may improve clinically in a relatively brief period of time. An important clinical 
feature of salmonellosis is the potential for some infected animals to shed the 
organism without demonstrating clinical signs of the disease (silent shedder). These 
inapparent carriers are capable of introducing the organism (although often in low 
numbers) into the environment to other susceptible hosts (Smith, 1979). 
 
1.5 Factors Influencing Infection 
There are a variety of factors that will influence the development of clinical 
salmonellosis. Some of these factors are related to the microorganism itself, such as 
the infective dose of bacteria and the virulence of individual strain. Other factors that 
influence infectivity are related to the host and its individual susceptibility. Studies in 
mice have demonstrated that the number of Salmonella enteritidis organisms required 
to infect conventionally raised animals is 106 or greater. However, in germ-free mice, 
only 10 bacteria were necessary to result in diarrhea, septicemia and death (Collins, 
1978). 
 
 Salmonella virulence is also dictated by a number of cellular components of the 
bacterium itself. These include adhesion molecules, toxins (cytotoxin, endotoxin, 
enterotoxin) and antimicrobial resistance. Some virulence factors are encoded in the 
microbial chromosome and some are located on extrachromasomal plasmids. 
Bacteria can acquire new virulence factors or modify their existing ones by two 
methods: spontaneous genetic mutations and transfer of DNA among bacteria. 

 


Spontaneous mutation are not common, however, because bacteria have a short 
generational interval, mutations can be propagated exponentially. Fortunately, 
spontaneous mutations do not impact virulence factors and antimicrobial resistance 
patterns to a large degree (Dargatz and Traub-Dargatz, 2004). Unfortunately, bacteria 
can also share virulence factors by horizontal gene transfer with other bacteria. Bacterial 
conjugation is the transfer of genes by cell to cell contact usually by means of pilli. 
Bacterial transformation is the ability of bacteria to acquire environmental DNA across 
the cell membrane and integrate it into its genome. Transduction is the method for 
acquiring genes through vectors such as bacteriophages. Through these methods, bacteria 
can effectively acquire resistant genes not only from Salmonella, but from different 
bacterial genera as well in recent decades, the emergence of highly-virulent, multidrug-
resistant Salmonella strains has become of great concern.  
 
1.6 Salmonella in Food 
Serovars of Salmonella enterica are the primary bacterial agents responsible for 
foodborne outbreaks of human gastrointestinal diseases. Among the different species, 
S. enteritidis and S. typhimurium serovars are of particular clinical importance. 
Salmonella spp. especially S. enterica serovars are pathogenic bacteria which 
frequently contaminate food products particularly those containing poultry, eggs, 
meat, dairy products, fruits and vegetables contaminated with animal feces or 
handling contaminated pet treats (Bearson, and Shawn, 2006; Poppe, et al., 2006; 
D’Aoust, 1991; Nguyen and Khan , 1994).  
 
In 1958, an outbreak of salmonella caused by foodborne S. enterica serotype hadar in 
Israel was linked to consumption of chicken liver. An investigation of the chicken 

 

farm found that bone meal fed to the chickens was contaminated with the same 
serotype of Salmonella (Hirsch, and Sapiro-Hirsch., 1958). Milk borne outbreak due 
to S. enterica serotype heidelberg in England in 1963 was traced to a cow with bovine 
mastitis due to the same organism. Chickens are usually infected by oral uptake of 
bacteria from the environment. Contaminated litter is the most important source of 
infection. Besides this horizontal transmission, vertical transmission through eggs is 
also considered as a source of infection in chickens (Poppe, 2000). It is known that S. 
enteritidis can persist in chicken organs and intestine and predominantly colonizes the 
carcass of the animal (Desmidt, et al., 1998a, 1998b). Between 1988 and 1992, 
averages of 110 outbreaks of Salmonella were reported each year to CDC (Bean et al., 
1996). Sixty percent of these outbreaks were caused by Salmonella serotype 
enteritidis and most of these were attributed to eating undercooked eggs. Many of 
these egg-associated outbreaks were traced back to their farm of origin and it was 
demonstrated that infected hens were the source of the outbreak. 
 
Outbreaks of Salmonella infections associated with eating Roma tomatoes were 
detected in the United States and Canada in the summer of 2004. An outbreak was 
characterized by a single Salmonella serotype. There were 561 cases in an  outbreak-
related illness from 18 states and one province in Canada. Although a single tomato-
packing house in Florida was common to all three outbreaks, other growers or packers 
also might have supplied contaminated Roma tomatoes that resulted in some of the 
illnesses. Because current knowledge of mechanisms of tomato contamination and 
methods of eradication of Salmonella in fruit is inadequate to ensure product safety, 
further research should be a priority for the agricultural industry, food safety agencies, 
and the public health community (CDC, 2005). 
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Figure2: Schematic representation of the cycling of NTS between animals, food and 
humans. 
   
                
An increase in antibiotic resistance was observed due to the emergence of an epidemic 
multidrug-resistant (MDR) strain of serotype Typhimurium of definitive phage type 
104 (DT104), especially in Europe and North America (Weill, et al., 2006; Threlfall, 
2000). In these DT104 isolates, multiple antibiotic resistances were due to 
chromosomal integration of a 43-kb structure called Salmonella genomic island 1 
(SGI1). Foods of animal origin are frequently implicated in human salmonellosis 
owing to the high prevalence of Salmonella strains in animals (Oosterom, 1991). The 
most frequent causes of infection by Salmonella reported in humans have been 
through the handling of raw poultry carcasses and products, together with the 
consumption of undercooked poultry meat (Panisello, et al., 2000).  
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The number of reported cases of salmonellosis has increased about threefold in the 
United States during the past 20 years (Tauxe, 1997). In the past, foodborne outbreaks 
were often local occurrences, affecting people who attended the same social event or 
who ate at the same restaurant (Slutsker, et al. 1998). Today, evidence suggests that 
outbreaks are increasingly cross provincial, territorial and national borders (Tauxe, 
and Hughes, 1996). Salmonellosis is responsible for heavy economic losses in both 
developing and developed countries to the commercial poultry industry through 
morbidity, mortality and reduced egg production (Pomeroy and Nagaraja, 1991).  
  
Among the more than 2,500 serotypes of the genus Salmonella described to date 
(Popoff, 2001), S. enteritidis and S. typhimurium, are predominant in many developed 
countries. S. enterica serotype typhimurium was the second most prevalent serotype 
(S. enteritidis ranked first) in Europe during the period 1998 to 2003 (Fisher, 2004). It 
has a large animal reservoir, including farm animals, pets, and wild animals. Although 
most Salmonella infections cause mild diseases (gastroenteritis), life-threatening 
infections (e.g., bacteremia) may occur, particularly in cases involving patients at the 
extremes of age or those who are immunocompromised.  
 
 Acquisition of an incompatibility group HI plasmid can encode simultaneously 
resistance to chloramphenicol, ampicillin, trimethoprim, sulfonamides, and 
tetracyclines (Couturier, et al., 1988; Fica, et al., 1997; Rowe, et al., 1997). Quinolone 
resistance, which is associated with chromosomal point mutations in the gyrA gene, 
has been also reported (Wain, et al., 1997). Studies showed that high rate of bacterial 
resistance to antibiotics in animals is likely due, in part, to selective pressure resulting 
from misuse of these antibiotics, improper treatment, prophylaxis or commonly given 

 

antimicrobial growth promoters (Barza, 2002; Pedersen, 1999; Witte, 2000; Van den 
Bogaard and Stobberingh, ,2000).  
 
Eradication of Salmonella isolates from the surrounding environment is almost 
unattainable. Therefore, preventive control measures must be adopted. Guidelines 
must be adopted to control contaminated sources such as primary animal production, 
slaughterhouses, and food-producing plants, careful handling of raw products and end 
products to limit the recurrence of disease. Therefore, poultry industry has to routinely 
apply detection techniques for Salmonella to assess contamination risk in their 
production chain. It is also desirable that the monitoring methods be applied to large 
numbers of samples at low costs. Early, diagnosis, laboratory-based surveillance 
including Salmonella serotyping and monitoring of resistance, immunization, and 
public education, is essential for prevention and control (Rijpens and Herman, 2002; 
Slutsker et al.,. 1998). Efforts for control of Salmonella are under way at the local, 
national and international levels to improve the capacity, coordination and 
cooperation of public and private laboratories, physicians, hospitals and public health 
officials (Slutsker, et al., 1998, Tauxe and Hughes, 1996). 
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1.7 Epidemiology  
Non-typhoidal salmonellosis is a foodborne disease of primary concern in developed 
as well as developing countries. The spread of this disease is favored by wide array of 
animal reservoir and by the wide commercial distribution of both animals and food 
products. It is one of the major public health problems in terms of socio-economic 
impact (Gracia and Finlay,1994) Global surveillance data indicates that incidence of 
gastrointestinal infections caused by S. enteritidis has increased massively during the 
last decades.  
 
 Food contamination with antibiotic-resistant bacteria can be a major threat to public 
health, as the antibiotic resistance determinants can be transferred to other bacteria of 
human clinical significance. The prevalence of antimicrobial resistance among food-
borne pathogens has increased during recent decades (Boonmar, et al., 1998; Chiu, et 
al., 2002; Davis, et al., 1999; Threlfall, 2000), possibly as the result of selection 
pressure created by the use of antimicrobials in food-producing animals (Threlfall, et 
al., 1997; Angulo, et al., 2000; Bywater, 2004; Teuber, 2001). The coexistence of 
resistance genes with mobile elements such as plasmids, transposons, and integrons 
facilitates the rapid spread of antibiotic resistance genes among bacteria (Sunde, et al., 
2006). Molecular analysis of antibiotic resistance genes and antibiotic-resistant mobile 
elements has shown that identical elements were found in bacteria that colonize both 
animals and humans, suggesting a role for raw foods in the dissemination of resistant 
bacteria and transfer of resistance genes to humans via the food chain (Levy, et al., 
1976; O'Brien, et al 1984; Teuber 2001).  
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 An increase of multidrug resistant Salmonella strains showing resistance against 
different antibiotics have been recovered from isolates of humans, poultry, and cattle 
origin in recent year (Esaki, et al., 2004). 
 
 Salmonella typhimurium DT104, resistant to streptomycin, chloramphenicol, 
amoxicillin, sulfonamides, and tetracyclines, is one of the strains that most frequently 
displays multiple resistance characteristics (Kristiansen, et al., 2003), additional 
resistance to quinolones, such as nalidixic acid and ciprofloxacin, has been described 
in recent years, thus increasing the importance in the public health area (Piddock, and 
Ricci 1998) 
 
Quinolones are widely used for treatment and prevention in animal production 
systems, particularly in the aviculture area. The Federal and Drug Administration 
(FDA), in docket N8 00N-1751, have prohibited the use of enrofloxacin in poultry, 
due to the increased resistance displayed by Campylobacter spp. (FDA, 2000). The 
antibiotic effect of quinolones depends on its ability to bind to the DNA gyrase 
complex inducing a conformational change in the enzyme (Hawkey, 2003). In 
Salmonella spp., as well as in E. coli and in the majority of gram-negative 
microorganisms, resistance to quinolones is determined fundamentally by two 
mechanisms: one corresponds to the alteration of the DNA gyrase binding site due to 
mutation between amino acids 67 and 106 of the QRDR region (Quinolone Resistance 
Determining Region) of the gyrA gene. The other mechanism corresponds to 
structural changes of the porins of the outer membrane of gram-negative 
microorganisms, which produce an alteration of the permeability of the bacteria to the 
antimicrobial agent (Reyna, et al., 1995). 

 

The most frequent mutation in gyrA gene which confer resistance to nalidixic acid, are 
those located at the Ser 83 or Asp 87 amino acids. The mutation in Ser 83 can change 
the amino acid to Phe, Tyr, or Ala, while the mutation in Asp 87 can change the 
amino acid for Gly, Asn, or Tyr. Double mutations for both amino acids confer 
resistance to ciprofloxacin, as observed in isolates of Salmonella spp. (Reyna, et al., 
1995). A less frequent mutation associated to resistance is found on amino acid Gly 
81, which is substituted for Asp or Cys (Giraud, et al., 1999).    
     
 Information on the phenotypes and genotypes of antimicrobial resistance in 
foodborne microorganisms is largely restricted to developed countries, and there is a 
paucity of information on what is happening in developing countries. Where they are 
reported, rates of resistance to antibiotics of bacteria originating from meat were high 
in developing countries (Al-Ghamdi, et al., 1999; Angkititrakul, et al., 2005; Chung, 
et al., 2003; Manie, et al., 1998; Taremi, et al., 2006), possibly as the result of the 
inappropriate or uncontrolled use of antibiotics in farming practices. Therefore, the 
study of antibiotic resistance in developing countries is important as the information 
could enhance prudent use of antibiotics in food production. In Palestine, antibiotic 
resistance has not been reported. However, as far as we are aware, there have been no 
published reports about the occurrence of antibiotic-resistant bacteria in raw food 
samples in Palestine and even no reports about the molecular characteristics of these 
antibiotic-resistant bacteria.  
 
 Several studies about salmonellosis have been recently done on children in Israeli 
hospitals. Salmonella was found in 25% of all stool cultures examined as compared to 
30% Shigella and 2% Campylobacter (Finkelstein, et al., 2002).  Another study 
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conducted from 1995 to 2003, had reported that the incidence of endemic fever was 
2.7 times higher in Arabs than Jews (Meltzer, and Yessepowitch, 2006).  
Investigations of diarrheal outbreaks among Israeli soldiers between 1998 and 2003 
revealed that Shigella, Salmonella and Staphylococcus spp. were the most commonly 
isolated organisms (Schwaber, et al., 2005). In a Jordanian study performed on 400 
patients with diarrhea, Salmonella was isolated in 2.3% of the cases (Shehabi et al, 
2001). In a case study performed on the swimming pools in the West Bank, 
Salmonella was the most commonly isolated organism (Al-Khatib and Salah., 2003).  
A study on the epidemiology of Salmonella and Shigella conducted from 2001 and 
2005 revealed that the majority of Salmonella spp. has affected children less than two 
years of age. Salmonella O group C, serovars virchow, hadar, newport and kentucky, 
and Salmonella O group B server typhimurium were the most common (Ghneim, et al 
2006). 
 
 
 
 
 
 
 
 
 
 
 
 

 
	
1.8 Therapy  
Acute salmonellosis is largely supportive. Aggressive intravenous fluids, treatments 
aimed at ameliorating the effects of endotoxemia (nonsteroidal anti-inflammatories, 
plasma, antisera, polymyxin B), and intestinal protectants are the mainstay of therapy. 
Probiotic therapy with commercial Lactobacillus preparations has shown from time to 
time benefits in salmonellosis through the production of inhibitory factors and 
competition for mucosal colonization. Antibiotic therapy in patients with Salmonella 
colitis remains a controversial area. Antibiotics are not indicated unless the patients 
are at high risk of developing septicemia, such as in the case of neonates or other 
immunocompromised patients. Fluoroquinolones are broad-spectrum antimicrobials 
effective in the treatment of a wide variety of clinical and veterinary infections and 
are the antimicrobials of choice for treatment of invasive gastrointestinal infections in 
adults, in many parts of the world. Salmonella gastroenteritis is usually treated with 
fluoroquinolones when the patient is elderly or immunocompromised (Hopkins, et al., 
2005). Many suspect that antibiotics may in fact prolong the period of bacterial 
shedding and there is increasing evidence that inappropriate antibiotic use may 
contribute to the emergence of drug resistant salmonellae through bacterial selection 
pressures.  
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1.9 Quinolones  
 1.9.1 Quinolones Structure 
Quinolones are synthetic antimicrobial agents belong to a group of potent antibiotics. 
Their structure contains two fused rings, with a carboxylic acid at carbon-3 and a 
ketone at carbon-4.  Nalidixic acid, the first generation quinolone and the only one 
approved for use in children, is a non-fluorinated compound synthesized in 1962 and 
still in use today (Figure 3). Modification of the nalidixic acid gave rise to the broad 
spectrum and highly effective drugs known as fluoroquinolones developed at the 
beginning of 1980s (e.g perfloxacin, ciprofloxacin, and ofloxacin) as shown in Figure 
4. This modification has a much greater activity against bacteria such as 
Enterobacteriaceae, Staphylococci, Pseudomonas aeruginosa, Mycoplasma and 
Chlamydia. The fluoroquinolones were synthesized by adding a fluorine atom at 
carbon-6 of the parent nalidixic acid compound (Leibovitz, 2006). 
 
Figure 3:  The chemical structure of the parent quinolone, nalidixic acid. 
 
Figure 4: The chemical structure of ciprofloxacin, a fluoroquinolone 
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1.9.2 Mechanism of Action and Spectrum of Activity 
Bacterial topoisomerases are a class of enzymes essential in maintaing the bacterial 
DNA molecule stable and biologically active including DNA gyrase, a type II DNA 
topoisomerase enzymes and topoisomerase IV (Leibovitz, 2006). DNA gyrase 
introduces supercoils into the linear DNA double helix, which results in the highly 
condensed 3-dimensional structure of the DNA usually present inside the cell. During 
the supercoiling process; both DNA strands are cleaved by DNA gyrase at 4 base pair 
staggered sites, forming a "quinolone binding pocket". Two quinolone molecules self-
assemble inside the pocket in dimer structure and attach to the gyrase-DNA complex 
electrostatically, which stabilizes the intermediate stage of this reaction step. 
Permanent gaps in the DNA strands induce synthesis of repair enzymes 
(exonucleases), initiating uncoordinated repair processes, which results in irreversible 
damage to the DNA and, finally, cell death. Topoisomerase IV found that in vitro, is 
to decatenate the daughter chromosomes in the final stages of DNA replication. 
 
 DNA gyrase consists of two proteins (A and B), with the active species being a 
heterotetramer (A2B2). Topoisomerase IV. Comprises two subunits, ParC and ParE. 
The ParC protein is homologous to the gyrase A protein, while the ParE subunit is 
homologous to the gyrase B protein. 
 
 Fluoroquinolones interfere with bacterial DNA metabolism by the inhibition of two 
enzymes, Topoisomerase II (DNA gyrase) and Topoisomerase IV. In Gram-negative 
bacteria DNA gyrase is the primary target, whereas in Gram-positive Topoisomerase 
IV was recently found to be most affected. 
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1.9.3 Pharmacology: 
Fluoroquinolones are generally well absorbed in the gastrointestinal tract. The newer 
fluoroquinoloes have improved pharmacokinetic properties compared with the older 
ones, in terms of longer serum half-life, higher peak levels leading to maximal 
bacterial killing and large volumes of distribution with subsequent extensive tissue 
penetration (Murray,and Baron, 1999). 
 
Pharmacokinetic data of fluoroquinoloes in pediatric patients are limited. Most studies 
have been performed in older children with cystic fibrosis and Pseudomonas spp.   
infections. Treatment of such infections requires higher dosage. It was reported by 
Capparelli et al. that rapid absorption and faster clearance of single-dose of 
gatifloxacin occurs in infants and children as compared with older children and adult 
patients (Capparelli et al 2005). 
 
 Quinolones have good penetration into the lungs, kidney, muscle, bone, intestinal 
wall, and extravascular body fluids. The concentration achieved in the prostate gland 
is approximately twice that in the serum. The concentration in the urine reaches 25 to 
100 times above peak concentrations in serum.  However, the concentration in the 
CSF is rather low (<1 µgml) in patients with meningitis. The Quinolones have the 
ability to penetrate well into phagocytes, reaching concentrations in the neutrophils 
and macrophages that are 14 times higher than that in the serum (Ferigin, and Cherry, 
1998). 
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1.9.4 Quinolone Resistance 
There are three main mechanisms of resistance to quinolones. First resistance to 
quinolones occurs with decreased expression of membrane porins. A second 
mechanism of resistance is expression of efflux pumps in both gram negative and 
gram positive organisms and the third is alteration of the target enzymes. Several 
mutations have been described in both quinolone target proteins that result in reduced 
binding affinities. It is believed that high-level quinolone resistance is brought about 
by a series of successive mutations in the target genes (Ruiz, 2003). 
 
DNA replication in bacteria occurs via semiconservative mechanism .The bacterial 
chromosome is circular and interwined.  Unwinding of the parental DNA strands 
during replication usually results in positive supercoiling that would impede the 
unwinding process.  This problem is overcome by the action of DNA gyrase which is 
capable of removing the positive DNA supercoils and restoring the unwinding 
process. 
 
 DNA gyrase is a tetramer consisting of two nonidentical subunits, A and B in the 
form A2B2.  The A and B subunits are encoded by the chromosomal genes gyrA and 
gyrB. The A subunit which is responsible for the breakage and ligation function is the 
primary target of Quinolones. It has been suggested that quinolones bind to the DNA 
and DNA gyrase complex causing the DNA strand to be cleaved. Quinolones can then 
inhibit ligation of the cleaved DNA, thus inhibiting the gyrase function by trapping 
the covalent enzyme-DNA intermediate (Murray, and Baron, 1999). 
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 Topoisomerase IV is a tetramer in the form A2B2. It is encoded by the parC and 
parE genes. Topoisomerase IV is a decatenating enzyme that resolves interlinked 
daughter chromosomes following DNA replication. Both, DNA gyrase and 
topoisomerase IV are necessary for cell growth and division.  Mutations in one or 
both genes encoding for the subunits of gyrase and topoisomerase IV may confer 
resistance to the bacteria against the quinolones. 
 
Among gram-negative pathogens, DNA gyrase is the primary target of the 
Quinolones. Alterations in the gyrA gene are primarily responsible for the 
development of resistance to this antibiotic. Multiple mutations are probably 
necessary for expression of high-level fluoroquinolones resistance. The most frequent 
mutation in quinolone resistant found in E. coli at the codon 83 of gyrA and in other 
Enterobacteria, such as Citrobobacter freundii, Shigella spp, Neisseria gonorrhoeae , 
Acinetobacter baumannii and S. typhimurium  (Ruiz, 2003). 
 
Decreased uptake of these antibiotics is another mechanism for resistance. Decreased 
quinolones uptake may be associated with two factors: an increase in the bacterial 
impermeability or the over expression of efflux pumps.  
 
Quinolones may cross the outer membrane in two different ways: through specific 
porin channels or by diffusion through the phospholipid bilayer. The degree of 
diffusion of a quinolone is greatly associated with and dependent on its level of 
hydrophobicity. All quinolones may cross the outer membrane through the porin 
channels, but only those with the greater level of hydrophobicity may diffuse through 
the phospholipid bilayer. Thus alterations in the composition of the porins and or in 
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the lipopolysaccharide-defective mutants, increase susceptibility to hydrophobic 
quinolones have been described, without alterations in the level of resistance to the 
hydrophilic quinolones. Alterations in membrane permeability are usually associated 
with decreased expression of porins. This has been described both in E. coli and other 
gram-negative bacteria (Ruiz, 2003). Recently, the discovery of plasmid-mediated 
quinolone resistance could result in horizontal transfer of resistance genes between 
strains (Hopkins, et al., 2005).  
           
Human salmonellosis caused by nontyphoidal Salmonella spp. occurs with increasing 
frequencies in developed countries. The emergence of fluroquinolone –resistant 
Salmonella stains is a serious problem. This class of antibacterial agents is considered 
to be the treatment of choice in cases of acute salmonellosis due to multi drug 
resistant strains (Giraud, et al., 1999). The increase in antimicrobial resistance has 
lead many countries to initiate surveillance program to monitor dissemination and 
detect the evolution of bacterial resistance (Varavithya, et al., 1990). 
 
It has been proposed that the uncontrolled use of antibiotics in veterinary medicine 
may promote the emergence of drug resistance bacterial pathogens. This can present a 
potential risk to public health due to zoonotic infections as seen with Salmonella and 
Campylobacter. It has been reported that quinolones are widely administered to farm 
animals in the United States and Europe. Objections have been raised against these 
practices in order to minimize the evolution of drug resistance against these 
antimicrobials (Piddock, and Ricci, 1998; Ruiz, 2003).  
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 This study was conducted to address some of these issues and to provide a current 
baseline of information on molecular characteristics of antibiotic resistance of 
Salmonella isolates from clinical specimens and foods commonly sold in the 
marketplace in Palestine. The isolates were investigated to determinate whether 
quinolone resistant Salmonella spp. From human as well as food samples harbor 
mutations in QRDR region of the gyrA gene 
 
1.10 Specific Aims 
Our specific aims in this study are the following: 
1. To properly identify Salmonella isolates  
2. To serotype Salmonella isolates using the somatic "O" and flagellar "H" antigens.  
3. To perform antimicrobial susceptibility testing by disk diffusion method. 
4. To determine the presence of gene gyrA responsible for quinolone resistance 
using PCR. 
5. To determine the specific mutation in the gene gyrA by sequencing. 
 
. 
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Materials and Methods 
2.1 Specimens 
A total of 151 non-typhoid Salmonella spp. were obtained from various clinical as 
well as food samples. Sixty-nine isolates were obtained from stool specimens, 2 
isolates were obtained from blood specimens from patients with gastroenteritis. These 
samples were collected from outpatient clinics in Bethlehem and East Jerusalem 
hospitals between September 2006 and October 2007. 
 
A total of 80 non-typhoid Salmonella spp. were obtained from contaminated food 
samples. These samples were provided by the Central Laboratory for Public Health at 
Ramallah between September 2005 and January 2007. 
  
Stool samples were collected in a dry, clean, leak proof plastic container early in the 
course of infection. Each sample was labeled with the child's name, gender, age, and 
area of residence and sent to the laboratory within 30 minutes of sample collection. 
 
2.2 Study population  
This is a cross-sectional study conducted on specimens taken from children less than 
ten years of age with diarrhea. All specimens containing Salmonella spp. were 
included in this study.  Most of the stool and blood specimens were collected from 
children ages from few days to less than 10 years. The specific age distribution of the 
patients is shown in Table 1. The source of the food samples is shown in Table 2 and 
figure 5.The geographical distributions of these patients are shown in Table 3.   
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Age (years) Number of samples Percentage 
< 2 61 86.0 
2 - 4 5 7.0 
4 – 6 2 2.8 
6 – 8 1 1.4 
8 – 10 1 1.4 
> 10 1 1.4 
Table 1: Age distribution of patients with salmonellosis 
 
Food Source) Number of samples Percentage 
Turkey 57 71.0 
Chicken 10 12.5 
Beef burger 4 5.0 
Cheese 3 3.8 
Tahini 2 2.5 
Halava 2 2.5 
Kinafa 1 1.3 
Water 1 1.3 
Table 2: Predominance of Salmonella species in food samples 
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Area Specimens 
City Stool Blood 
Bethlehem 14 1 
Jerusalem 0 1 
Hebron 3 0 
Beit sahour 6 0 
Beit jala 6 0 
Camp   
Dehesha 3 0 
Aida 1 0 
Azzeh 1 0 
Aroub 2 0 
Village   
Dar Salah 1 0 
Nahhalin 1 0 
Kisan 1 0 
Urtas 1 0 
Battir 1 0 
Kharas 1 0 
Wad Rahhal 2 0 
Beidiyeh 3 0 
Doura 2 0 
Asakre 1 0 
Al Rashaideh 1 0 
Nouba 2 0 
Beit Ummar 3 0 
Sawahreh sharkeyh 1 0 
Abu Injeim 1 0 
Beit Fajjar 1 0 
Ta'amreh 1 0 
El Walajeh 2 0 
Al khader 3 0 
Aqbet Jaber 1 0 
Tqou' 2 0 
Beit Ula 1 0 
Table 3: Geographic distribution of stool and blood specimens 
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Figure 5: Predominance of Salmonella species in different food sources. 
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2.3 Laboratory diagnosis 
2.3.1 Routine analysis 
 The stool sample is mixed well and examined for leukocytes, red blood cells and 
parasites. 
 
2.3.2 Bacterial culture  
Routinely, stool samples were inoculated on MacConkey agar (Oxoide LTD 
England), XLD agar ( Oxoid LTD England), 5% blood agar (Oxoid LTD England), 
Campy agar ( Oxoid LTD England), and in selenite broth ( Biolife Italy). 
Patients samples were incubated at 35oC for 24 hours, API20E kit was purchased 
from Biomerieux (France), and biochemical test were performed on suspected 
colonies Salmonella non-lactose fermenter on MacConkey and red with black center 
on XLD. Biochemical tests included urea broth (oxoide LTD England), Triple sugar 
iron (TSI) slants (Oxoid LTD England), SIM (Biolife Italy), Citrate agar slants 
(Biolife Italy), and mannitol (Merck Germany). 
 
Confirmation and typing of Salmonella isolates was done with Salmonella O groups 
antisera (A, B, C, D, and E) purchased from Israel Ministry of Health using slide 
agglutination method according to the manufacturer guidelines. 
 
2.3.3 Salmonella identification 
 Suspected colonies on XLD agar plates with the following biochemical reaction: 
urea: negative, TSI: alkaline/ acid with H2S, motile and gas producer. Conformation 
of the Salmonella isolates was done by typing with anti-sera specific for salmonella 
“O” and Salmonella “H” antigens.  
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Isolates identified as salmonella were subcultured on MacConkey agar plates; few 
colonies were inoculated into sterile eppendorf tubes in 1 ml Mueller Hinton broth 
containing 20% glycerol and stored at -4o C for further study. Antimicrobial 
susceptibility of Salmonella isolates was determined using disc diffusion method 
according to M-100-S14 Clinical Laboratory Standard Institute (CLSI) guidelines. 
 
2.4 Antimicrobial susceptibility testing 
Salmonella inoculated in sterile saline and adjusted to the turbidity of 0.5 McFarland 
Standard. Aliquots were spread on plates of Muller Hinton agar by sterile cotton 
swabs. Using aseptic techniques, sterile forceps was used to place a disc of antibiotics 
on the surface of MH-agar plate containing the inoculated bacterial isolate. 
Antibiotics  which were used are shown in Table 4. 
The plates were incubated at 37o C for 18 to 24 hours. The zone of inhibition around 
each antibiotic disc was measured with a Vernier Caliber to the nearest millimeter. 
Resistant (R), intermediate (I) or susceptible (S) zone diameters were recorded 
according to the recommendations and guidelines by CLSI.  
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Antibiotic Name Concentration Abbreviation 
Ampicillin 10ug AMP 
Co-trimethoprim 25ug SXT 
Nalidixic acid 30ug NA 
Tetracycline 30ug TE 
Chloramphenicol 30ug C 
Erythromycin 15ug E 
Ciprofloxacin 5ug CIP 
Ceftriaxone 30ug CRO 
Oflaxcin 5ug OFX 
Gentamicin 10ug CN 
Table 4: Antibiotic discs used in the disc diffusion method for antimicrobial 
susceptibility testing of salmonella isolates 
 
2.5 PCR detection of quinolones genes in Salmonella  
2.5.1 Sample preparation: 
Salmonella were subcultured on MacConkey agar plates and incubated at 37o C for 18 
to 24 hours. A half-loopful of bacterial growth was removed from each plate and 
suspended in 200µl of sterile distilled water. The suspension was heated for 15 
minutes at 95o C to release DNA template. The suspension was then centrifuged at 
14,000 rpm for 2 min to precipitate undesired substances. Five µl of supernatant (cell 
lysate) containing the DNA template was added to 22 µl of PCR reaction mixture 
(Kariuki, et al., 2004). 
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2.5.2 PCR mixture preparation: 
Reaction conditions consisted of 50 ng of plasmid DNA and 100 nM concentration 
from the primer GYRA 1 and GYRA 2 were used  (Table 5) in a buffer composed of 
10 mM Tris-HCL (PH 8.3), 50 Mm KCL, 1.5 Mm MgCl 2, a 200 µM deoxynucleoide 
triphosphate mixture, and 1U of Taq polymerase in a final volume 100 µl. 
Primer 
Name 
Oligonucleotide sequence (5 -3) Primer 
size (b) 
product 
size (bp) 
GYRA1 ATGAGCGACCTTGCGAGAGAAATTACACCG 30 630 
GYRA2 TTCCATCAGCCCTTCAATGCTGATGTCTTC 30  
b: base 
bp: base pair  
Table 5: The gyrA primer used for PCR amplification and Sequencing of genes 
encoding for quinolone resistance (Kariuki, et al., 2004). 
2.5.3 DNA amplification 
The amplification condition was set in the cycler to run 35 cycles, with denaturation at 
94o C for 30 s, annealing at 55o C for 30s, and extension at 72o C for 30s, with a final 
extension step of 72o C for 10 min (Kenya, et al., 2004). 2% agarose gel 
electrophoresis was used to confirm that the PCR product obtained was correct. The 
PCR product was then digested by HinfI (Fermentas). 
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2.6 DNA Restriction and Agarose Gel Electophoresis 
2.6.1 HinfI restriction fragment length polymorphisms 
Restriction was achieved by adding 2 µl HinfI (5 U), 2µl buffer to 16 µl PCR product 
in a total volume of 20µl and incubated up to 2 hours at 37 o C.  The digested DNA 
was run on 2 % agarose gel. The size of fragments was then determined against a 50 
bp ladder which was included in the run and the gel were photographed.  
 
2.6.2 Agarose gel electrophoresis 
The agarose gel was prepared as follows: 
Agarose (2% w/v) were prepared in 25ml of Tris-EDTA buffer (TAE). The agarose was 
dissolved by heating then cooled to 50o C, and 2 µl of ethidium bromide (10mg/ml) was 
added. The gel was then poured into the electrophoresis cell. After solidification of the 
gel at room temperature, 1X TAE buffer was added to the electrophoresis cell, and the 
comb was carefully removed. 10 µl of PCR products was mixed with 2 µl of blue orange 
dye and then loaded. A 50 bp DNA marker was also included. The gel was run at 80V for 
10 min then 120V for 30 minutes, viewed on a UV transilluminator and photographed. 
 
2.7 DNA Sequencing: 
The amplified PCR products from Salmonella isolates containing gyrA gene were purified 
using purification kit ( Promega ) and sequenced directly using ABI PRISM (310 genetic 
analyzer – Applied Biosystem) using big dye terminator  VI.I cycle. 
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Results 
Non-typhoid Salmonella spp. isolated from patients with gastroenteritis was obtained 
from several hospitals and outpatient clinics in Bethlehem and Jerusalem between 
September 2006 and October 2007. It is been noticed that most of the isolates were 
collected between June and October 2007 (Figure 6). 
 
The isolates were kept at -20o C in Tryptic Soy Broth containing 20% glycerol. Non-
typhoid Salmonella spp. was obtained from contaminated food samples were collected 
between September 2005 and January 2007. The bacterial isolates were then streaked 
on MacConkey and XLD agar plates to recover the Salmonella isolates 
Seasonal variation of salmonella  in clinical samples 
collected 2006 - 2007
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Figure 6: Seasonal variation of non-typhoid Salmonella isolates between Sep. 2006 
and Oct. 2007   
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3.1 Biochemical Identification and Serotyping 
The primary identification of Salmonella was done on the basis of non-lactose 
fermentation and hydrogen sulfide production on TSI slants and then by API20e. All the 
isolates obtained for this study were non-typhoid Salmonella spp. The most commonly 
encountered serotypes in both the clinical isolates (47/71) and food isolates (52/80) were 
Salmonella type O group C.  The results of serotyping are summarized in table 6 and 
Figure 7. 
 Clinical isolates Food Isolates 
Serogroup Number of isolates Percentage Number of isolates Percentage 
C 47 66.2 52 65.0 
D 17 23.9 4 5.0 
B 6 8.5 21 26.0 
A 1 1.4 0 0.0 
E 0 0.0 3 4.0 
Total 71 100 80 100 
Table 6:  Predominant serogroups of non-typhoid Salmonella spp. obtained from 
clinical isolates and food sources. 
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Figure 7: Predominance of Salmonella spp. serotypes isolated from food and clinical 
specimen. 
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3.2 Antimicrobial susceptibility  
Antimicrobial susceptibility testing was performed on a total of 10 antibiotics for both 
clinical and food isolates. The results for the antimicrobial susceptibility testing were 
interpreted according to the sensitive, intermediate, resistance system. The number of 
clinical and food isolates susceptible to both nalidixic acid and ciprofloxacin were 
found to be 27/71 and 41/80 respectively. The number of clinical and food isolates 
resistant to nalidixic acid but susceptible to ciprofloxacin were found to be 21/71 and 
24/80 respectively. The number of clinical and food isolates resistant to both nalidixic 
acid and ciprofloxacin were found to be 21/71 and 12/80 respectively. The results of 
the antimicrobial susceptibility testing are summarized in Tables 7, 8, 9, 10, 11, 12,  
13, and 14 and with their figures 8, 9, and 10. 
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Isolate ID Identification AMP E NA cip TE GN 
A5 S.O.C R R R R R R 
B9 S.O.C R R R R R R 
C1 S.O.C R R R R R R 
C2 S.O.C R R R R R R 
C3 S.O.C S R R R R S 
C5 S.O.C R R R R R R 
C6 S.O.C R R R R R R 
D6 S.O.C R R R R R R 
D7 S.O.C R R R R R R 
D9 S.O.C R R R R R R 
E3 S.O.C R R R R R R 
E4 S.O.C R R R R R R 
F2 S.O.C R R R R R R 
G1 S.O.C R R R R R R 
G6 S.O.C R R R R R R 
H3 S.O.C R R R R R R 
H6 S.O.C R R R R R R 
H7 S.O.C R R R R R R 
H8 S.O.C R R R R R R 
H9 S.O.C R R R R R R 
I4 S.O.C R R R R R R 
Table 7: Results of antimicrobial susceptibility testing for clinical isolates of 
Salmonella with the serotype resistant to Na and Cip, S.O.C: Salmonella O group C. 
S: sensitive, R: resistance, I: intermediate 
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Isolate ID Identification AMP E NA Cip TE GN 
A2 S.O.D R R R S R S 
B2 S.O.D S R R S S S 
B5 S.O.C S R R S S S 
B6 S.O.C R R R S R S 
B8 S.O.C R R R S R S 
C4 S.O.C R R R S R S 
D8 S.O.D R R R S R S 
E1 S.O.D R R R S S S 
F3 S.O.C S R R S R S 
F7 S.O.C S R R S R S 
F9 S.O.C S R R S R S 
G3 S.O.C S R R S S S 
G7 S.O.C S R R S S S 
G8 S.O.C S R R S R S 
G9 S.O.C S R R S R S 
H1 S.O.C S R R S R S 
H2 S.O.C S R R S S S 
H4 S.O.C S R R S R S 
H5 S.O.C S R R S S S 
I3 S.O.C S R R S S S 
I5 S.O.B R R R S R S 
Table 8: Results the antimicrobial susceptibility testing for clinical isolates of 
Salmonella with the serotype resistant to NA but sensitive to Cip S.O.C : Salmonella 
O group C, S.O.B: Salmonella O group B, S.O.D: Salmonella O group D. S: sensitive, 
R: resistance, I: intermediate. 
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Isolate ID Identification AMP E NA Cip TE GN CRO 
A1 S.O.D R R S S S S S 
A3 S.O.D R R S S S S S 
A4 S.O.D R R S S S S S 
A9 S.O.D R R S S S S S 
B1 S.O.D R R S S S S S 
B3 S.O.C R R S S I S S 
B4 S.O.D R R S S S S S 
C7 S.O.B R R S S R S S 
C8 S.O.B R R S S R S S 
D1 S.O.C R R S S S S S 
D2 S.O.C R R S S S S S 
D3 S.O.C R R S S R S S 
D4 S.O.B S R S S S S S 
D5 S.O.D R R S S R S S 
E5 S.O.C S R S S S S S 
E6 S.O.C S R S S S S S 
E7 S.O.D I R I S R S S 
E8 S.O.A S R S S I S S 
E9 S.O.D I R I S R S S 
F1 S.O.D S R S S I S S 
F4 S.O.D S R S S S S S 
F5 S.O.D S R S S S S S 
F6 S.O.D S R S S S S S 
F8 S.O.C S R S S S S S 
G2 S.O.C I R S S S S S 
G4 S.O.C S R S S S S S 
G5 S.O.B R R S S R R S 
I1 S.O.D S R S S S S S 
I2 S.O.C R R S S R S S 
Table 9: Results of antimicrobial susceptibility testing for clinical isolates of 
Salmonella with the serotype sensitive to both Na and Cip, S.O.C: Salmonella O 
group C, S.O.B: Salmonella O group B, S.O.D: Salmonella O group D, S.O.A: 
Salmonella O group A. S: sensitive, R: resistance, I: intermediate. 
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Isolate ID SPECIMEN Identification Amp E TE NA Cip GE 
FA4 TURKY S.O.C R R R R R R 
FA5 TURKY S.O.C R R R R R R 
FA7 CHICKEN S.O.C R R R R R R 
FB1 TURKY S.O.C R R R R R R 
FB2 TURKY S.O.C R R R R R R 
FE4 TURKY S.O.C R R R R R I 
FF5 TURKY S.O.C R R R R R I 
FF6 TURKY S.O.C R R R R R I 
FF9 TURKY S.O.C R R R R R I 
FG2 TURKY S.O.C R R R R R R 
FG8 CHICKEN S.O.C R R R R R R 
FI7 CHICKEN S.O.C R R R R R R 
Table 10: Results of antimicrobial susceptibility testing of Salmonella isolates from 
food samples with the serotype resistant to both Na and Cip, S.O.C: Salmonella O 
group C. S: sensitive, R: resistance, I: intermediate. 
 
Isolate ID SPECIMEN Identification Amp E TE NA Cip GE 
FF4 TURKY S.O.B R R R R S S 
FG1 TURKY S.O.B R R R R S S 
FG9 TURKY S.O.B R R R R S S 
FH3 CHICKEN S.O.C S R R R S S 
FH4 TURKY S.O.B S R S  R S S 
FH5 TURKY S.O.B R R R R S S 
FH8 TURKY S.O.D R R R R S S 
FH9 TURKY S.O.C S R S  R S S 
FI1 TURKY S.O.C R R R R S S 
FE7 TURKY S.O.B R R R R S S 
FE5 CHICKEN S.O.B S R R R S S 
FD3 TURKY S.O.B R R R R S S 
FD1 TURKY S.O.B R R R R S S 
FC2 TURKY S.O.B R R R R S S 
FC3 TURKY S.O.B R R R R S S 
FC4 TURKY S.O.B R R R R S S 
FB9 TURKY S.O.B R R R R S S 
FA8 CHICKEN S.O.C R R S  R S S 
FA9 TURKY S.O.B R R R R S S 
FB3 TURKY S.O.C R R R R S S 
FB4 TURKY S.O.C R R R R S S 
FB7 TURKY S.O.C S R R R S S 
FA1 TURKY S.O.B R R R R S S 
FA2 CHICKEN S.O.C S R R R S S 
Table 11: Results of antimicrobial susceptibility testing of Salmonella isolates from 
food samples with the serotype resistant to Na but sensitive to Cip, S.O.C: Salmonella 
O group C, S.O.B: Salmonella O group B, S.O.D: Salmonella O group D. S: sensitive, 
R: resistance, I: intermediate  
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Isolate ID SPECIMEN Identification Amp E TE NA cip GE 
FI2 TURKY S.O.C R R R S S S 
FI3 TURKY S.O.C S R R S S S 
FI4 KONAFA S.O.C S R S  S S S 
FI5 TIHENIA S.O.E S R S  S S S 
FI6 TIHENIA S.O.E S R S  S S S 
FI8 TURKY S.O.D S R R S S S 
FH7 HALAWA S.O.C S R S  S S S 
FH6 HALAWA S.O.C S R R S S S 
FH1 TURKY S.O.B S R S  S S S 
FH2 CHICKEN S.O.E S R R S S S 
FG3 TURKY S.O.B S R I S S S 
FG4 TURKY S.O.B S R R S S S 
FG5 BEEF MEAT S.O.C S R R S S S 
FG6 BEEF MEAT S.O.C S R I S S S 
FG7 CHICKEN S.O.D S R R S S S 
FF7 TURKY S.O.C S R R S S S 
FF8 TURKY S.O.C R R R S S S 
FE8 TURKY S.O.C S R R S S S 
FE9 TURKY S.O.B S R R S S S 
FF1 TURKY S.O.C S R R S S S 
FF2 TURKY S.O.C S R S  S S S 
FF3 WATER S.O.C S R R S S S 
FE6 CHICKEN S.O.C S R R S S S 
FD5 TURKY S.O.C R R R S S S 
FD6 TURKY S.O.C S R R S S S 
FD7 TURKY S.O.C S R R S S S 
FD8 TURKY S.O.C S 9 R S S S 
FD9 TURKY S.O.C S R R S S S 
FE1 TURKY S.O.C R R R I S S 
FE2 CHEESE S.O.C R R R S S S 
FE3 CHEESE S.O.C S R R S S S 
FC5 BEEF burger  S.O.C S R S  S S S 
FC6 BEEF burger S.O.C S R S  S S S 
FC7 CHEESE S.O.D S R S  S S S 
FC8 TURKY S.O.C R R S  I S S 
FC9 TURKY S.O.C R R R S S S 
FD2 TURKY S.O.C R R R S S S 
FD4 TURKY S.O.C R R R I S S 
FB8 TURKY S.O.B S R R S S S 
FC1 TURKY S.O.C S R R S S S 
FB5 TURKY S.O.C R R R S S S 
FB6 TURKY S.O.B S R R S S S 
FA3 TURKY S.O.C R R R S S S 
FA6 TURKY S.O.C S R R S S S 
Table 12: Results of antimicrobial susceptibility testing of Salmonella isolates fom 
food samples with the serotype sensitive to both Na and Cip, S.O.C: Salmonella O 
group C, S.O.B: Salmonella O group B, S.O.D: Salmonella O group D, S.O.E: 
Salmonella O group E. S: sensitive, R: resistance, I: intermediate 
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 Clinical Isolates Food 
Drugs S I R S I R 
AMP 27 2 42 39 0 41 
CRO 71 0 0 80 0 0 
C 63 2 6 76 0 4 
SXT 64 0 7 76 0 4 
CN 49 0 22 68 4 8 
TE 26 3 42 13 3 64 
ER 0 0 71 0 0 80 
NA 27 2 42 41 3 36 
CIP 50 0 21 65 3 12 
OFX 50 0 21 65 3 12 
Table 13: Summary of the antimicrobial susceptibility testing of the Salmonella spp. 
performed on the clinical and food isolates. S: sensitive, R: resistance, I: intermediate 
 
Quinolones Pattern Clinical Food 
NA / CIP SS 27 41 
NA / CIP RS 21 24 
NA / CIP RR 21 12 
Table 14: Summary of antimicrobial susceptibility for the clinical and food isolates in 
terms of susceptibly and resistance to both nalidixic acid and ciprofloxacin. 
 

 

Susceptibility of NTS from Clinical samples
0.00
25.00
50.00
75.00
100.00
%
S 38.03 90.14 69.01 36.62 38.03 70.42 70.42 88.73 100.0 0.00
R 59.15 9.86 30.99 59.15 59.15 29.58 29.58 8.45 0.00 100.0
AMP SXT CN TE NA CIP OFX C CRO ER
 
Figure 8: Antimicrobial susceptibility of NTS obtained from clinical specimens.  
Susceptibility of NTS isolated from food to 
antibiotics
0
25
50
75
100
%
S 48.75 95 85 16.25 51.25 81.25 81.25 95 100 0
R 51.25 5 10 80 45 15 15 5 0 100
AMP SXT CN TE NA CIP OFX C CRO ER
 
Figure 9: Antimicrobial susceptibility of NTS obtained from foods.  
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Figure 10: Patterns of susceptibility of NTS isolated from food and clinical specimens 
to quinolones. 
 
3.3 PCR Results: 
The gyrA gene was amplified by PCR. The PCR products were analyzed on agarose 
gel electrophoreasis. A sharp band with 630 bp size measured against 50 bp ladder 
was obtained.  Representative photographs of the gels are shown below in figures 11, 
(A, B, C and D).  The PCR product was subjected to restriction by Hinf I enzyme. 
Various size bands were obtained depending on the pattern of susceptibility or 
resistance of Salmonella isolates to nalidixic acid and ciprofloxacin. Depending on 
susceptibility to these two antibiotics, 3 patterns were identified: sensitive to both 
(SS), resistant to nalidixic acid but susceptible to ciprofloxacin (RS) and resistant to 
both (RR). 
 
 Restricted and amplified DNA from the Salmonella isolates with the SS pattern 
revealed 3 major bands of 250 bp, 150 bp and 100 bp bands. A faintly appearing 
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fourth band of about 130 bp was also seen. Identical results were obtained with the RS 
group. With RR pattern, two major bands of 350 bp and 150 bp were evident. A 
faintly appearing third band of 130 bp was also seen in Table 15. The results of these 
experiments are shown in Figures 12 (E, F, G, and H) 
 
Table 15: Restricted and amplified DNA from the Salmonella with SS, RS, and RR 
patterns  
 
3.4 Sequencing Results 
Representative samples for the three patterns identified previously as SS, RS and RR 
were sequenced. The sequence obtained for the SS pattern was normal without any 
mutation as shown in figure 13. The sequence obtained with the RS pattern revealed a 
mutation at position 87. A substitution of G to A (GAC became TAC) that has 
resulted in the replacement of D (Aspartic acid) amino acid by Y (Tyrosine)  as shown 
in figure 14 The sequence obtained with the RR pattern revealed two mutations at 
positions 83 and 87. At position 83, a substitution of C to T (TCC became TTC) that 
has resulted in the replacement of S (Serine) by F (Phenylalanine). At position 87, the 
same type of mutation occurred as in the RS pattern, a substitution of G to A (GAC 
became TAC) that has resulted in the replacement of D (Aspartic acid) amino acid by 
Y (Tyrosine). The results of the sequencing are shown in Figure 15. 
Quinolones Pattern Rescriction band sizes 
NA / CIP SS 250 bp 150 bp 100 bp 
NA / CIP RS 250 bp 150 bp 100 bp 
NA / CIP RR 350 bp 150 bp  
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Figure 11 (A,B,C,and D) gel electrophoresis for the primary PCR products against 50 
bp DNA ladder. A band size of 630 bp was obtained for the gyrA gene. 
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Figure 12: Represent the restriction fragments of gyrA gene produced by HinfI.   
E: Lane 1 (M), 50 bp ladder, lane 2, gyrA gene from SS pattern, lane 3 restriction 
pattern in lane 2, lane 4, gyrA for RS pattern, lane 5, restriction pattern in lane 4, lane 
6 gyrA from RR pattern, lane 7, restriction pattern in lane 6.  
F: lane 1 (M) 50 bp ladder, lane 2 restriction pattern in lane 3, Lane 3, gyrA gene from 
RR pattern, 4 and 8 are the restriction pattern, lanes 5 and 7 are the gyrA gene for RR 
pattern.   
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Figure12:  Represent the restriction fragments of gyrA gene produced by Hinf I.  
 G: Lane 1(M), 50 bp ladder, lane 2, gyrA gene from RS pattern, lane 3 restriction 
pattern in lane 2, lane 4 and 6 are gyrA from RS pattern. 
  H:  gyrA for the SS pattern, lane 1 (M), 50 bp ladder, Lanes 6, 7 and 8 for gyrA gene 
from SS pattern. Lanes 2, 3, 4 and 5 are the restriction pattern.   
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Figure 13: The sequence for SS pattern was normal without any mutation.    
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Figure14. The sequence for RS pattern with a mutation at position 87, (GAC became TAC.) 
Figure15: The sequence for RR pattern with two mutations at position 83 and 87, (TCC 
became TTC and GAC became TAC) 
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Discussion 
Nontyphoidal salmonellosis is a significant public health problem worldwide. Most of 
the cases are found in the developing countries. In the United States, Salmonella is 
considered to be the most common enteric pathogen and most frequently isolated 
from children younger than 5 years of age (CDC 2004, CDC 2005 and CDC 2006). In 
US, an estimated 1.4 million cases occur per year with 15,000 hospitalization and 400 
fatal cases (Stevenson, 2007). 
 
In this study, it was found that the most commonly contaminated foods with 
salmonellae were turkey (71%), chickens (13%), ground meat (5%) and cheese (4%). 
Serotyping of the non-typhoid Salmonella spp. isolated from food revealed that 
groups C (52/80) was the most common followed by group B (21/80). Non-typhoid 
Salmonella spp. was also isolated from clinical specimens. The majority of the 
isolates were from children less than 4 years of age (95%). Group C Salmonella was 
the most common (47/71) followed by group D (17/71). 
 
Resistance of Salmonella to antibiotics has increased in several parts of the world 
posing a problem to healthcare systems worldwide. Fluoroquinolones are the most 
commonly used antimicrobial agents for the treatment of severe Salmonella infection 
in adults (Stevenson., 2007; Hopkins, et al., 2005).  Several studies have suggested 
that the use of fluoroquinolones in veterinary medicine contributes to the emergence 
and dissemination of nalidixic acid resistance in Salmonella among food animals, 
which may be transmitted to human. These data contributed to the decision by FDA in 
the United States to discontinue the use of fluoroquinolones in chickens and turkeys 
as of September 2005 (Stevenson., 2007). In Europe, the rate of quinolone resistance 
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is also very high (Threlfall, et al., 2003). Antimicrobial susceptibility testing 
performed according to CLSI guidelines, revealed a high rate of resistance to many 
antibiotics. The highest resistance rate was associated with nalidixic acid.  Resistance 
to nalidixic acid among isolates of NTS in Belgium had doubled during the period of 
2000 - 2003 to 84% (Stevenson, et al., 2007). Other studies resistance to nalidixic 
acid, among other prevalent Salmonella serovars in Israel, was less common of 54% 
(Mates, et al., 2002). 
 
In our study, resistance to nalidixic acid in clinical and food samples was found to be 
59.2% and 45% respectively. This rate is comparable to the rate reported in Israel. In 
the United States, Resistance of NTS to nalidixic was monitored from 1996 to 2003. 
Resistance to nalidixic acid in the year 2003 was 2.3 % as compared to 0.4% in 1996, 
a 7-fold increase. A study conducted in Mexico over 3 years period, revealed the 
presence of Salmonella in high percentage in pork and poultry (Zaidi, et al., 2006). 
These strains of Salmonella were resistant to nalidixic acid (27%) but not to 
ciprofloxacin. In Vietnam, a similar study evaluated drug resistance of Salmonella 
from pork and poultry, it reported a nalidixic acid resistance of 18.7% but none of 
these isolates was found to resistant to ciprofloxacin (Hao, et al., 2007). 
 
In this study a high level resistance to ciprofloxacin was found in both clinical 
specimens as well as in food samples, 30 % and 15% respectively. Several studies 
conducted on quinolone resistance in food did not report any resistance to 
ciprofloxacin (Hao, et al., 2007; Weill, et al., 2006). 
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The resistance of Salmonella spp. to ampicillin, tetracycline trimethoprim-
sulphamethoxazole, ceftriaxone and gentamicin was evaluated (Stevenson, 2007). In 
our study, resistance to ampicillin by Salmonella isolated from food and clinical 
samples were found to be 51.3% and 59.2 % respectively. A study conducted in Korea 
(Sang Ho Choi, et al., 2005) on human isolates of non-typhoid Salmonella revealed an 
ampicillin resistance of 39.1%, much lower than our results.  A Brazilian study 
revealed a resistance to ampicillin of 7.0% (Oplustil, et al.,  2001) as compared to 
resistance rates of 60.3% in Argentina, 20.0% in Coloumbia, and 16.7% in Mexico 
(Oplustil, et al., 2001). Resistance to tetracycline was found to be high in this study 
(59.2% for clinical isolates and 80% for food isolates). In a Korean study (Choi, et al., 
2005), they reported a resistance rate of 69%.  
 
Resistance to other antibiotics tested in our study included trimethoprim sulfa-
methaxozole (SXT), gentamicin and ceftriaxone. Resistance to these antibiotics in the 
human isolates was found to be 9.9%, 30.9%, and 0 % respectively. In a similar study 
conducted in Korea, the pattern of resistance to these antibiotics was 15.2%, 45.7% 
and 0% respectively. Resistance to ampicillin seems to be a big problem world wide 
for both non-typhoid as well as typhoidal Salmonella isolates. Outbreaks of multidrug 
resistance in S. typhi to ampicillin, SXT and chloramphenicol were reported in India, 
Arabian Gulf states, Phillipines and South Africa (Kariuki, et al., 2004).  
 
Quinolone Resistance of Salmonella enterica from human and poultry is of major 
concern to health care facilities. Studies on the QRDR region revealed that mutations 
in gyrA can be sufficient to cause high-level resistance to nalidixic acid in Salmonella 
(Giraud, et al., 2006).  
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In this study we screened clinical specimens as well as food samples for mutations in 
the gyrA gene. The reason is to detect the existence of high incidence of resistance 
among the isolates. Initially the gyrA gene was amplified and restricted and then 
resolved on agarose gel electrophoresis. Representative bands on all groups were then 
sequenced to definitely identify the presence and nature of mutations.   
 
Amplification of the gyrA gene and subsequent agarose gel electrophoresis revealed a 
band of 630 bps.  Restriction of the PCR products by Hinf I resulted in various bands 
that correlate with the pattern of susceptibility and resistance to nalidixic acid and 
ciprofloxacin. Three different patterns were identified in terms of nalidixic acid 
/ciprofloxacin: SS, RS and RR.  
 
Similar to the results of this study, for the different serovars with the Asp 87 Tyr 
substitution, the nalidixic acid MICs were between 64 and 512 g/ml and 
ciprofloxacin MICs were between 0.125 and 1 g /ml, lower MICs than for strains 
with other mutations in the codons of Asp87 or Ser83 (Galan and Wolf-Watz, 2006). 
Results obtained in our study for the amplification of the gyrA gene gave a band size 
of 630 bp for all Salmonella isolates. Review of literature revealed that our study are 
comparable to other studies done in India (Brown, et al., 1996), the United Kingdom 
(Brown and Shanahan 1996),) and Kenya (Kariuki, et al., 2004). The primers we used 
in this study were identical to those used in these papers.    
 
Restriction by Hinf I enzyme resulted in different band sizes depending on the pattern 
of susceptibility to nalidixic acid and ciprofloxacin. The SS and RS patterns of the 
NTS isolates revealed 3 major bands of 250 bp, 150 bp and 100 bp. A faintly 
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appearing fourth band of about 130 bp was also seen. With the RR pattern, two major 
bands of 350 bp and 150 bp were evident. A faintly appearing third band of 130 bp 
was also seen. Review of literature revealed similar results to those obtained by us. A 
similar study conducted in India (Brown and Thomson, 1996). On S. typhi, 
susceptible to both nalidixic acid and ciprofloxacin, resulted in 4 bands of 246 bp, 99 
bp, 149 bp and 126 bp. The number of bands and their sizes obtained for the S. typhi 
strains in the Indian study is almost identical to the number of bands and their sizes 
obtained in our study. Another study was conducted in Santiago Chile (Martin, et al., 
2004) Salmonella isolated from poultry. Although the primers used were different, the 
outcomes of their study were similar to those obtained by us. The outcomes of these 
experiments indicated a mutation on the gyrA gene at positions 83 or 87 depending on 
the pattern of resistance. 
  
Representative samples for the three patterns identified previously as SS, RS and RR 
were sequenced. The sequence obtained for the SS pattern was normal without any 
mutation. The sequence obtained with the RS pattern revealed a mutation at position 
87. A substitution of G to T (GAC became TAC) that has resulted in the replacement 
of aspartic acid to tyrosine. The sequence obtained with the RR pattern revealed two 
mutations at positions 83 and 87. At position 83, a substitution of C to T (TCC 
became TTC) that has resulted in the replacement of Serine by phenylalanine. At 
position 87, the same type of mutation occurred as in the RS pattern, a substitution of 
G to A (GAC became TAC) that has resulted in the replacement of aspartic acid by 
tyrosine.  The results obtained in this study are comparable with those obtained by 
Brown, J. C. (Brown, et al., 1996). In his study, it was reported that at position 83, a 
mutation occurred (TCC-TTC) that resulted in the replacement of serine by 

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phenylalanine. It was also reported that at position 87, a mutation occurred (GAC – 
TAC) that resulted in the replacement of aspartic acid by tyrosine, similar to the 
results obtained by us. In the same study, double mutation was observed in strains 
resistant to both nalidixic acid and ciprofloxacin (RR pattern). Here the mutations has 
occurred at both positions simultaneously, 83 and 87 with replacement of aspartic acid 
by tyrosine at position 87 and serine by phenylalanine at position 83. In another study 
conducted in Japan by Hirose, J (Hirose, et al., 2002). Identical results of double 
mutations at positions 83 and 87 were obtained with RR-pattern. In the RS pattern, 
either a mutation at position 87 or a mutation at position 83 were identified.  In our 
study, for the RS-pattern, only one mutation was identified at position 87. The 
difference between the Japanese study and ours could be resolved by sequencing more 
specimens belonging to the RS–pattern. 
 
The relationship between Salmonella serotypes and the mutation (s) carried in gyrA 
has not yet been fully studied. A study by Giraud et al suggested that mutations at Ser 
83 and Asp 87 may not be equally distributed among different serovars (Giraud et al., 
1999). In this study complete serotyping was not carried out but the strains were 
differentiated into five serogroups (A, B, C, D and E).  It has been noticed that most 
RR and RS in clinical as well as food isolates were of serogroup C. Further studies 
should be carried out to completely serotype the strains into their serovars and 
correlate the prevalence of mutation (s). 
 
 
 

 
	
Recommendations 
It is apparent from this study as well as many others, the dangers of using antibiotics 
in general in animal feed and quinolones in particular. It is clear that quinolones are 
used to treat severe Salmonella infections. Evolution of resistance to this class of 
antibiotics is extremely dangerous and may contribute to the spread of multidrug 
resistance Salmonella among humans. In the United States, the FDA prohibits the use 
of quinolones in animals and animal feed. This explains the quinolone resistance in 
that country of 2.3% as compared to much higher rates in third world countries 
(59.2% in our study) and Latin America. The Ministry of Health in Palestine must 
take this issue in consideration and implement stringent rules to regulate the use of 
certain antibiotics in animal feed and to prohibit the use of others such as the 
quinolones. 
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